A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Clinical trial NCT04077099 · RECRUITING
Trial details
- NCT number
- NCT04077099
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-07
- Primary completion
- 2032-04-22
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.